More Press Releases

View Older Stories View Newer Stories

Apr 6, 2024 03:50AM PremiumToken Officially Launches April 15th: Holders compete for a prize of $250,000!
Apr 5, 2024 09:30AM Innovative Outcomes (OTC:UBQU) Announces Distribution Agreement With MDM Wound Ventures to Distribute New EZE Debride System to Healthcare Professionals in 4.95 Billion Dollar Market
Apr 4, 2024 08:00AM LifeQuest's Wholly Owned Subsidiary Receives an Order for a 30m3/Day (7,900 Gallons/Day) Sewage Wastewater Treatment Plant From a Hospital in India
Apr 4, 2024 06:30AM Itronics Positioned to Benefit From Historic High and Rising Gold Prices
Mar 27, 2024 08:30AM LiveOne (NASDAQ: LVO) Hosts Event Celebrating Women in the Entertainment Industry
Mar 27, 2024 08:00AM Expanding Horizons: A New Chapter for BrewBilt Manufacturing
Mar 26, 2024 08:30AM US Nuclear Delivers First Batch of Tritium Monitoring Systems to Nation's Largest Public Power Company
Apr 6, 2024 01:39AM National Parks and Wildlife Service (NPWS) Statement
Apr 6, 2024 12:50AM VinFast wins two prestigious awards at the Bangkok International Motor Show 2024
Apr 6, 2024 12:35AM Experiencing Growth and Excellence with Trans Obra's Franchise Opportunities
Apr 5, 2024 11:31AM Bag Bunch Online Handbag Fashion Magazine Expands With New Designer Reviews
Apr 5, 2024 11:30AM Web TV Hub For Latest Online News & Celebrity Gossip Scoops: Website Launched
Apr 5, 2024 11:29AM UEFA Euro 2024 Teams, Stadiums & Schedule Breakdown: Ultimate Guide Launched
Apr 5, 2024 11:30PM Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
Apr 5, 2024 11:18PM Trial Attorney Andrew Pickett Secures $6.6 Million Verdict in a Personal Injury Case Against State Farm Mutual Automobile Insurance Company
Apr 5, 2024 11:21PM CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
Apr 5, 2024 11:10PM ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
Apr 5, 2024 11:05PM TSX Venture Exchange Stock Maintenance Bulletins
Apr 5, 2024 10:45PM Avangrid Statement on Gas Subsidiaries’ Response to 4.8 Magnitude Earthquake
Apr 5, 2024 10:26PM Společnosti Mercedes-Benz a BYD spojují své síly a vyvíjejí nový vůz DENZA pro globální expanzi společnosti BYD
Apr 5, 2024 09:43PM ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors
Apr 5, 2024 09:38PM Herbalife Expects to Complete $1.6 Billion Secured Refinancing on April 12
Apr 5, 2024 09:36PM Herbalife Announces Pricing of Upsized $800 Million Aggregate Principal Amount of Senior Secured Notes Offering
Apr 5, 2024 09:00PM UNITED ALERT: Bragar Eagel & Squire, P.C. is Investigating United Airlines Holdings, Inc. on Behalf of United Stockholders and Encourages Investors to Contact the Firm
Apr 5, 2024 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Blue, and Luna Innovations and Encourages Investors to Contact the Firm
Apr 5, 2024 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, and Shoals and Encourages Investors to Contact the Firm
Apr 5, 2024 09:00PM XPONENTIAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Xponential Fitness, Inc. and Encourages Investors to Contact the Firm
Apr 5, 2024 08:55PM Statement by the Prime Minister on the passing of the Honourable Iona Campagnolo
Apr 5, 2024 08:49PM Ecopetrol Announces Senior Management Changes
Apr 5, 2024 08:40PM CPI Aerostructures Reports Fourth Quarter and Full Year 2023 Results
Apr 5, 2024 08:32PM FIBRA Macquarie México Announces First Quarter 2024 Earnings Conference Call
Apr 5, 2024 08:30PM Antengene Presents Four Preclinical Posters at AACR 2024
Apr 5, 2024 08:05PM AMC Networks Announces Early Results of Tender Offer for Any and All 4.75% Senior Notes due 2025
Apr 5, 2024 08:04PM Federal, provincial and territorial labour ministers discuss key challenges facing workers in Canada
Apr 5, 2024 08:02PM Early Warning Report In Respect of Joshua Crumb’s Holdings in Abaxx Technologies Inc.
Apr 5, 2024 08:00PM RBC announces changes to its executive team
Apr 5, 2024 08:00PM Early Warning Press Release
Apr 5, 2024 07:50PM Ecopetrol S.A.'s Board of Directors Announcement
Apr 5, 2024 07:46PM NAIC Adopts First National Climate Resilience Strategy for Insurance to Close Coverage Gaps and Improve Recovery from Natural Disasters
Apr 5, 2024 07:46PM FREE SPRING BREAK DAY CAMP @ ALCOHOL JUSTICE
Apr 5, 2024 07:33PM ParcelPal Announces Share Consolidation
Apr 5, 2024 07:32PM Phase Four Accelerates Mission with Announcement of Distinguished Board of Advisors
Apr 5, 2024 07:25PM bettermoo(d)’s Moodrink(TM) Now on Shelves in Over 400 Stores of Canada's Largest Grocery Retailer
Apr 5, 2024 07:27PM Společnost Bybit nastavuje v odvětví laťku svým prověřováním rezerv: 40 ověřených tokenů
Apr 5, 2024 07:23PM Bayridge Announces Grant of Stock Options and Restricted Share Units
Apr 5, 2024 07:16PM Hilco Streambank Overseeing Chapter 11 Sale of Action Face, Inc. 3D Avatar & Action Figure Technology Company Includes Assumable NBA Sublicense & HP 3D-Printing Agreement
Apr 5, 2024 07:15PM FlipSandal Introduces Patented Convertible Flip Flop Sandal, Aiming to Transform Footwear Industry
Apr 5, 2024 07:02PM Pender Growth Fund Provides Financial Highlights and Company Updates
Apr 5, 2024 07:00PM Oberon Uranium Closes Acquisition of Mineral Claims in Saskatchewan
Apr 5, 2024 07:00PM Infotel's Morgan Attias to Address Long-Term Data Preservation Concerns for High-Profile Executives at InfoNEXT Conference
View Newer Stories View Older Stories